Navigation Links
Autism Consortium releases data on genes involved in autism to researchers worldwide
Date:10/22/2007

BOSTON OCTOBER 22, 2007 The Autism Consortium, a group of researchers, clinicians and families dedicated to radically accelerating research and enhancing clinical care for autism, announced today that it has completed the first genome scan for Autism Spectrum Disorders (ASD) through its Autism Gene Discovery Project and has released the reference data set to a database that autism researchers around the world can use. The scan was conducted using new, high resolution technology developed by Affymetrix on genetic data from more than 3,000 children with ASD and their families.

Todays release of genetic and phenotypic data on autism marks a significant achievement for the autism research community, said Thomas Insel, Ph.D., Director of the National Institute for Mental Health. Progress in finding the causes and cures for autism spectrum disorders rests in large part on improving the rapid access and sharing of data and resources That the Consortium is making the data available to the scientific community even before its own researchers have fully analyzed the information, demonstrates their high degree of commitment to and leadership in advancing autism research.

Along with complementary data generated by Dr. Aravinda Chakravarti at Johns Hopkins and provided to the NIMH this week, these data provide the most detailed look to date at the genetic variation patterns in families with autism.

Mark Daly, PhD, a Consortium member with the Center for Human Genetic Research at Massachusetts General Hospital and a senior associate member of the Broad Institute of Massachusetts Institute of Technology and Harvard, released genetic data from genome wide scans of DNA variation collected from 3,000 individuals who are either affected by autism spectrum disorders, or are family members of individuals with autism. DNA samples for this scan were provided by the Autism Genetic Resource Exchange (AGRE), a program of Autism Speaks, dedicated to ac
'/>"/>

Contact: Kathryn Morris
kathryn@kmorrispr.com
845-635-9828
The Autism Consortium
Source:Eurekalert

1

GOOD

Page: 1 2 3 4

Related medicine news :

1. Antibiotics Helps Autism
2. Early diagnosis for autism from blood tests may be possible
3. Latest discovery on Autism
4. Resolving Autism
5. Studying The Causes Of Autism
6. Mercury Pollution Linked To Rise In Autism
7. Early identification of autism possible
8. Autism risks linked to birth factors
9. Autism epidemic is a myth- says a new study
10. Treating Autism More Effectively
11. MMR Vaccination not linked to Autism
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...G, Pa., Sept. 5 /PRNewswire-USNewswire/ -- Childre...r access to comprehensive,services to protect thei...n,in grants that were announced today by the Depar...vices for children and families, the department,be...ren,s Services Planning,initiative, ICSP, in 2004....
(Date:9/5/2008)..., Md., Sept. 5 /PRNewswire-USNewswire/ -- The Heal...day announced $39 million in grants to,increase an...centers., "These grants continue President Bush,s...whose services now reach more economically,vulnera...r before," HRSA,Administrator Elizabeth M. Duke sa...
(Date:9/5/2008)...ontrolled, but you need to know what triggers them...thDay News) -- If you are one of the 36 million Am...is nowhere in the United States that is free from ... shows. , Allergies don,t only happen in the sp...ell. In the fall, the most challenging cities to l...
(Date:9/5/2008)...N, Sept. 5 /PRNewswire-USNewswire/ -- Speaker Nanc...upport of the aims of the "Stand,Up to Cancer" tel...re is not a person in our country who has not seen...s 565,000 Americans annually, and each,year there ... must work,together to make eradicating the scourg...
Breaking Medicine News(10 mins):Health News:Pennsylvania Counties Receive Grants to Improve Services for Children 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:No Place Safe From Allergies 2
...earch findings show men have fewer long-term gastr...radiation therapy (IMRT) than with three-dimension...tate cancer treatment, despite the higher doses of...r data, including long-term genitourinary side eff...
...s , which is also called the silent killer, is s... and many may be unaware of the disease// they are... world , followed by the US . In fact one in six o...hich means that they have higher than normal blood...
... largest patients' rights body led by US-based AID...for the hundreds of thousands of people in West Be...nated blood as a result of faulty blood-test kits ...kits were supplied by Secunderabad-based company M...
...od actor Mickey Rourke says he has calmed down wit... else has failed.// Rourke said he no longer jump...'The other day, there was some drunk guy troubling... benefit of the doubt and I told the waitress, 'I ...
Other Medicine News:Health News:IMRT Versus 3D CRT For Prostate Cancer, New Long-Term Data Assesses Side Effects 2Health News:Worldwide Diabetes Figures Alarmingly High 2Health News:Compensation Demanded For Bengal's Blood Scam Victims 2
(Date:9/3/2008)...umatology Research and Education Foundation,s Wit... in Detecting, Treating and Un...For the first time during its,unprecedented initia...American College of Rheumatology Research and Educ...ired from research funded by the Within Our,Reach:...
(Date:9/3/2008)...nal Vascular Disease Awareness Month, CHARLOTTESV...aceuticals,LLC, a clinical-stage drug-development ...t of unmet medical needs, announced today that it ...cal trial of its lead drug,candidate trans sodium ...81,on the clinicaltrials.gov Website, is investiga...
(Date:9/3/2008)...3 /- Panacea Pharmaceuticals,Inc. to...,413,737 covering,antibodies against human asparty...tary human cancer biomarker and therapeutic target... with the Massachusetts Institute of,Technology (M... this patent,for development of human cancer diagn...
(Date:9/3/2008)...iscuss Phase 3 Plans with FDA, PRINCETON, N.J., S...nnounced today that it successfully completed two ...any,s new, innovative low-dose, once-weekly,contr... internal product,code AG-200-15. The Phase 2b saf...y endpoint of ovulation suppression, cycle control...
Breaking Medicine Technology:New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis 2New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 2Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 4Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 2Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 3Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 4Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 2Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 3Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 4CBaySystems Commitment to Continued Improvement Leads to High Industry Recognition 10251 1CBaySystems Commitment to Continued Improvement Leads to High Industry Recognition 10251 2Intervention program boosts health reduces symptoms in breast cancer patients 10247 1Intervention program boosts health reduces symptoms in breast cancer patients 10247 2Intervention program boosts health reduces symptoms in breast cancer patients 10247 3Mental health screenings risk behavior interventions needed in juvenile justice system 10246 1Mental health screenings risk behavior interventions needed in juvenile justice system 10246 211 Minutes or 90 Seconds 3F 10241 111 Minutes or 90 Seconds 3F 10241 2
...ofrontera AG (DSE: B8F) announces today,that it ha...ng part,of its phase IIb/III clinical trial starte...the active substance 5-aminolevulinic acid,(ALA) w...ificantly,superior to placebo in the treatment of ...mic therapy, which eliminates tumor tissue,through...
...at Study in American Heart Journal , ,WINNIPEG, M...Amex:MCU), a cardiovascular focused, biopharmaceut...ollow-up results from the,STRATEGY (Single High-Do...sus Abciximab and Bare Metal Stent In Acute Myocar...edition of the Journal,of the American College of ...
Other Medicine Technology:Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy,of BF-200 ALA In Actinic Keratosis 2Positive Aggrastat Results Featured in the Journal of the American,College of Cardiology 2Positive Aggrastat Results Featured in the Journal of the American,College of Cardiology 3Positive Aggrastat Results Featured in the Journal of the American,College of Cardiology 4Positive Aggrastat Results Featured in the Journal of the American,College of Cardiology 5
SmartOffice Plus is a CO2 laser system with continuous intensities up to 25 W. Its functions in continuous and super-pulsed mode are ideal for surgery requiring extreme laser intervention delicacy. E
Auto Refkeratomoeter
Developed to meet the infusion needs in NICU, Anesthesia and Critical Care, the AUTO SYRINGE AS50 Infusion Pump delivers precise, controlled infusions.
The FLO-GARD 6201 Volumetric Infusion Pump and the FLO-GARD 6301 Dual-Channel Volumetric Infusion Pump are industry standard in standard set infusion pump technology.
Medicine Products: